Target intelligence / Profile preview

T cell receptor delta variable 2 (TRDV2)

Target
TRDV2
Molecular classification
T cell receptor subunit, Immunoglobulin superfamily
01

Overview

The Vdelta2 chain is a variable region of the delta (δ) chain in the γδ T cell receptor (TCR), specifically forming part of the most common γδ TCR in human peripheral blood: the Vgamma9Vdelta2 TCR. The pairing of the Vgamma9 and Vdelta2 chains enables these cells to recognize specific non-peptide antigens, particularly phosphoantigens produced by microbes and tumor cells. Upon antigen recognition through its CDR loops—especially CDR3—the receptor triggers rapid innate-like immune responses including cytokine production (e.g., IFN-gamma, TNF-alpha). Engineering αβ T-cells to express the Vγ9Vδ2 receptor can endow them with new anti-tumor properties due to their ability to detect phosphoantigens commonly upregulated in cancerous tissues. Modified versions have been designed for dual specificity against tumors expressing both phosphoantigens and integrins such as αvβ6.

Other names
Vdelta2 chainVδ2 chainTCRDV2
02

Mechanism of action

Modulation of T cell receptor signaling through antigen binding

03

Biological functions

Antigen recognitionT cell activationCytokine productionImmune response
04

Disease associations

InfectionCancerAutoimmunity (potential)
05

Safety considerations

Potential for off-target effects in engineered T cell therapiesCytokine release syndrome

Beyond the preview

Go deeper on T cell receptor delta variable 2 (TRDV2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor delta variable 2 (TRDV2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call